the public has a perception, which I think is fairly grounded in reality, that industries like the PBM industry, the pharmaceutical industry, there are many more but, just for today's proceedings, have undue influence on how policy gets made in Washington with respect to drug pricing and all kinds of other things.
Sarbanes discusses public concerns about pharmaceutical industry influence on policy.
Share
More from John Sarbanes
Maryland's total-cost-of-care model also allows our State to invest in other health system goals, like lowering the maternal mortality rate and the opioid overdose mortality rate.
Due to testing positive for COVID-19 and following recommended isolation protocols, I was unable to vote. Had I been present, I would have voted ``aye'' on rollcall No. 125, ``aye'' on rollcall No. 126, ``aye'' on rollcall No. 127, ``aye''…
I thank the gentlewoman for yielding me time. Mr. Chair, I rise with respect to an amendment that I introduced with Congressman Bilirakis that has already been made part of the en bloc, which has been agreed to. I am very appreciative of…
Other voices in this conversation
